BRCA1 and ovarian cancer: We tested 147 buffy coat samples from patients with breast and/or ovarian cancer to detect germline variants by next-generation sequencing using the IonAmpliSeqTM BRCA1/2 Panel or Oncomine®BRCA1/2 Panel.